Wat heescht "Clear"?
D'Déier huet d'Mutatioun net. Et wäert d'Krankheet net entwéckelen a wäert et net weiderginn.
The DNA test for Achromatopsia Type 3 (PRAcd) in German Shorthaired Pointers is essential for responsible breeding. This genetic screening identifies carriers of the PRAcd mutation, which causes progressive vision loss and color blindness in affected dogs. Early detection through DNA testing helps breeders prevent passing this hereditary condition to future generations. By using the PRAcd test, owners can ensure healthier litters and maintain the breed’s overall well-being. Regular testing supports informed breeding decisions and promotes the longevity of German Shorthaired Pointers. Protect your dog’s vision and contribute to breed health with the Achromatopsia Type 3 DNA test.
The DNA test for Achromatopsia Type 3 (PRAcd) in German Shorthaired Pointers helps identify carriers and affected dogs. This inherited condition causes complete color blindness and vision problems. Early testing allows breeders to make informed decisions to reduce the risk of passing the disorder. By screening breeding dogs, the prevalence of PRAcd can be minimized in future generations. Responsible breeding ensures healthier dogs with better quality of life.
Dësen DNA Test ass abegraff ab eisem Pack Basic - an ass och Deel vun de Pak Basic, Standard, Advanced, Complete.
View DNA Test Packs →Achromatopsia Type 3, also known as Progressive Retinal Atrophy with complete color blindness (PRAcd), is a hereditary condition that affects the vision of German Shorthaired Pointers. This genetic disorder results from mutations in specific genes that are crucial for the proper functioning of photoreceptor cells in the retina, leading to vision impairment over time.
Dogs affected by Achromatopsia Type 3 typically exhibit symptoms such as a lack of color vision, difficulty seeing in bright light, and potential night blindness. Owners may notice that their dogs have trouble navigating their environment, particularly in brightly lit areas, as their ability to perceive colors is significantly diminished.
This condition is inherited in an autosomal recessive manner, meaning that both copies of the gene must be mutated for the dog to express the disease. Carriers, which have one normal and one mutated gene, do not show symptoms but can pass the condition to their offspring. Identifying carriers through DNA testing is essential for responsible breeding practices, as it helps prevent the propagation of the condition in future generations.
While Achromatopsia Type 3 can lead to significant visual impairment, many dogs adapt well to their condition. Owners can assist by providing a safe environment and ensuring that their pets are comfortable in low-light conditions or areas with bright lighting. Understanding the limitations of their dog's vision allows owners to make necessary adjustments to enhance their pet's quality of life.
Managing a dog with Achromatopsia Type 3 primarily involves environmental modifications rather than medical interventions. Owners should ensure that their living space is free from obstacles that could pose a danger, as affected dogs may not respond to visual cues in the same way as their sighted counterparts. Regular veterinary check-ups are also advised to monitor the dog's overall eye health and address any other potential issues that may arise.
Achromatopsia Type 3 in German Shorthaired Pointers is a serious genetic condition that affects visual perception. Understanding the symptoms, genetic basis, and management strategies is crucial for owners and breeders alike. Through responsible breeding and proper care, the impact of this condition on affected dogs can be alleviated, allowing them to lead fulfilling lives despite their visual challenges.
D'Déier huet d'Mutatioun net. Et wäert d'Krankheet net entwéckelen a wäert et net weiderginn.
Nee D'Déier ass allgemeng gesond mee kann d'Mutatioun un seng iwwerdroen Nofolger.
Et huet zwee mutéiert Exemplare. Klinesch Zeeche ginn erwaart jee no der Krankheet. Et soll net gefeelt ginn.
E puer Krankheeten sinn Geschlecht verbonnen, sou datt hiren Ausdrock variéiert jee no der Geschlecht vum Déier.
This DNA test detects the mutation associated with Achromatopsia Type 3 In German Shorthaired Pointer (PRAcd) in order to identify clear, carrier, or at-risk animals.
DNA Testen hëlleft Züchter méi sécher Maten ze plangen an de Risiko ze reduzéieren fir d'Mutatioun un d'Nofolger ze iwwerdroen.
Den Ierfschaftsmodus fir dësen Test gemellt ass Autosomal Recessive.
This test analyses the mutation CNGB3 c.784G>A.
Net onbedéngt. D'Interpretatioun hänkt vum Ierfschaftsmuster an dem resultéierende Genotyp of.
Sidjanin Duska J, Lowe Jennifer K, McElwee John L, Milne Bruce S, Phippen Taryn M, Sargan David R, Aguirre Gustavo D, Acland Gregory M, Ostrander Elaine A. Canine CNGB3 mutations establish cone degeneration as orthologous to the human achromatopsia locus ACHM3. Hum Mol Genet. 2002 Aug 1;11(16):1823-33. doi: 10.1093/hmg/11.16.1823.
Är Privatsphär, Äre Choix
Mir benotze wesentlech Cookien fir d'Websäit ze lafen. Optional Cookien (wéi embedded Inhalt Provider) sinn als Standard deaktivéiert a sinn nëmmen aktivéiert wann Dir averstanen ass. Dir kënnt Äre Choix zu all Moment mat der "Cookien" Knäppchen änneren.
Néideg fir Kär Funktiounen a Sécherheet. Ëmmer aktivéiert.
Verbessert Funktiounen wéi Präferenz spueren oder Net-Reklamm Embeds.
Hëlleft eis d'Benotzung vum Site ze verstoen. Standard behënnert.
Annoncéieren / Tracking iwwer Siten (e puer Video / Kaarten embeds). Standard behënnert.